Private Trust Company’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $346K | Buy |
7,188
+2,169
| +43% | +$101K | 0.03% | 566 |
|
|
2025
Q4 | $243K | Buy |
5,019
+103
| +2% | +$5.11K | 0.02% | 687 |
|
|
2025
Q3 | $232K | Sell |
4,916
-892
| -15% | -$43K | 0.02% | 695 |
|
|
2025
Q2 | $281K | Buy |
5,808
+1,588
| +38% | +$81.1K | 0.03% | 596 |
|
|
2025
Q1 | $234K | Buy |
4,220
+697
| +20% | +$37.7K | 0.02% | 655 |
|
|
2024
Q4 | $170K | Sell |
3,523
-134
| -4% | -$6.81K | 0.02% | 756 |
|
|
2024
Q3 | $211K | Buy |
3,657
+137
| +4% | +$7.4K | 0.02% | 677 |
|
|
2024
Q2 | $171K | Buy |
3,520
+584
| +20% | +$28.2K | 0.02% | 708 |
|
|
2024
Q1 | $143K | Buy |
2,936
+847
| +41% | +$41.4K | 0.02% | 750 |
|
|
2023
Q4 | $104K | Sell |
2,089
-715
| -25% | -$35K | 0.01% | 819 |
|
|
2023
Q3 | $150K | Sell |
2,804
-103
| -4% | -$5.49K | 0.02% | 654 |
|
|
2023
Q2 | $157K | Buy |
2,907
+205
| +8% | +$11K | 0.02% | 648 |
|
|
2023
Q1 | $147K | Buy |
2,702
+474
| +21% | +$23.1K | 0.02% | 638 |
|
|
2022
Q4 | $108K | Sell |
2,228
-343
| -13% | -$15.1K | 0.02% | 706 |
|
|
2022
Q3 | $98K | Buy |
2,571
+162
| +7% | +$7.22K | 0.02% | 686 |
|
|
2022
Q2 | $121K | Buy |
+2,409
| New | +$128K | 0.02% | 627 |
|
|
2017
Q1 | – | Sell |
-10,455
| Closed | -$422K | – | 370 |
|
|
2016
Q4 | $422K | Sell |
10,455
-712
| -6% | -$28.1K | 0.1% | 234 |
|
|
2016
Q3 | $426K | Buy |
11,167
+940
| +9% | +$37.7K | 0.1% | 222 |
|
|
2016
Q2 | $428K | Sell |
10,227
-139
| -1% | -$5.7K | 0.11% | 211 |
|
|
2016
Q1 | $416K | Buy |
10,366
+122
| +1% | +$4.9K | 0.11% | 211 |
|
|
2015
Q4 | $436K | Sell |
10,244
-1,049
| -9% | -$48.3K | 0.12% | 194 |
|
|
2015
Q3 | $536K | Buy |
11,293
+169
| +2% | +$8.61K | 0.16% | 166 |
|
|
2015
Q2 | $550K | Buy |
11,124
+1,350
| +14% | +$68.4K | 0.16% | 168 |
|
|
2015
Q1 | $483K | Buy |
+9,774
| New | +$467K | 0.14% | 194 |
|
|
2014
Q4 | – | Sell |
-794
| Closed | -$45K | – | 1050 |
|
|
2014
Q3 | $45K | Sell |
794
-1
| -0.1% | -$54 | 0.02% | 580 |
|
|
2014
Q2 | $42K | Sell |
795
-52
| -6% | -$2.76K | 0.01% | 608 |
|
|
2014
Q1 | $44K | Sell |
847
-176
| -17% | -$8.91K | 0.02% | 521 |
|
|
2013
Q4 | $55K | Sell |
1,023
-53
| -5% | -$2.73K | 0.02% | 436 |
|
|
2013
Q3 | $54K | Sell |
1,076
-543
| -34% | -$27.6K | 0.02% | 415 |
|
|
2013
Q2 | $83K | Buy |
+1,619
| New | +$86.3K | 0.04% | 309 |
|
Other funds holding SNY
MIP
Private Trust Company's SNY Position: Q1 2026 in Review
Private Trust Company increased its Sanofi (SNY) stake by 43% in Q1 2026, buying an estimated $101K and bringing the position to 7,188 shares worth $346K. The position accounts for 0.03% of the portfolio, ranked #566.
Private Trust Company first reported a position in SNY in Q2 2013 and has held it in 30 quarters since. The position peaked at $550K in Q2 2015. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Private Trust Company held 7,188 shares of Sanofi worth $346K as of Q1 2026.
- Private Trust Company bought 2,169 Sanofi shares in Q1 2026, an estimated $101K.
- Sanofi made up 0.03% of Private Trust Company's portfolio in Q1 2026, its #566 holding.
- Private Trust Company first reported a position in Sanofi in Q2 2013 and has held it in 30 quarters since.
- Private Trust Company's Sanofi position peaked at $550K in Q2 2015.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.